Thomas A. Davis

机构：Uniformed Services University of the Health Sciences

发表论文 84 篇 · 总被引 5291 次 · h-index 33

代表论文

• Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial (2017 · The Lancet Oncology · 被引 1124)
• Rindopepimut with Bevacizumab for Patients with Relapsed EGFRvIII-Expressing Glioblastoma (ReACT): Results of a Double-Blind Randomized Phase II Trial (2020 · Clinical Cancer Research · 被引 179)
• The traumatic bone: trauma-induced heterotopic ossification (2017 · Translational research · 被引 148)
• Safety and Activity of Varlilumab, a Novel and First-in-Class Agonist Anti-CD27 Antibody, in Patients With Advanced Solid Tumors (2017 · Journal of Clinical Oncology · 被引 132)
• Scleraxis-Lineage Cells Contribute to Ectopic Bone Formation in Muscle and Tendon (2016 · Stem Cells · 被引 114)
• Heterotopic ossification and the elucidation of pathologic differentiation (2017 · Bone · 被引 81)